CPACT Welcomes Novo Nordisk
New CPACT Member -
09-07-2025
CPACT is happy to announce that Novo Nordisk has recently joined our consortium
Novo
Nordisk is a global healthcare company with over 100 years of innovation and
leadership in diabetes care. Based in Denmark, the company is dedicated to
driving change to defeat diabetes and other serious chronic conditions such as
obesity and rare blood and endocrine disorders. With a strong focus on
research, development and production of innovative medications, Novo Nordisk is
committed to improving the lives of people through sustainable access to
high-quality healthcare solutions. Beyond its medical advancements, the company
is also deeply engaged in promoting awareness, education and support for
individuals affected by these conditions, embodying its vision to pioneer a
world where healthcare is available to everyone, improving the quality of life
for millions worldwide.
We look forward to working together.